Journal Article

Erratum

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 30, issue 3, pages 632-632
Published in print March 2000 | ISSN: 1058-4838
Published online March 2000 | e-ISSN: 1537-6591 | DOI: http://dx.doi.org/10.1086/313740
Erratum

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

In the meeting summary in the November 1999 issue (Ernst JD. Toward the development of antibacterial vaccines: report of a symposium and workshop. Clin Infect Dis 1999; 29:1295–302), there were 2 errors in the summary of the presentation given by Lee Wetzler (“Development of Neisseria Vaccines”). The second sentence of the second paragraph should begin “Neisserial porins have been characterized as potential vaccine targets …,” instead of “Porin and Rmp have been characterized as potential vaccine targets …” The first sentence of the last paragraph of the summary should read as follows: “In a study of female contacts of male index cases of gonococcal urethritis, the risk of acquiring infection was lower for women with a higher ratio of antibodies to porin and lipo-oligosaccharide, compared with antibodies to Rmp, while transmission was higher for women with a lower ratio of anti-porin or lipo-oligosaccharide antibodies, compared with Rmp antibodies.”

In addition, the names of several participants and members of the organizing committee of the vaccine workshop were omitted. The list should read as follows: Naomi Balaban, University of California, Davis; Alan Barbour, University of California, Irvine; George F. Brooks, University of California, San Francisco; Henry F. Chambers, University of California, San Francisco; Joanne N. Engel, University of California, San Francisco; Joel D. Ernst, University of California, San Francisco; Stanley Falkow, Stanford University; Julie L. Gerberding, Centers for Disease Control and Prevention; J. MacLeod Griffiss, University of California, San Francisco; W. Scott Harkonen, Connective Therapeutics, Inc.; Keith Klugman, South Africa Institute for Medical Research, University of Witwatersrand; Jane E. Koehler, University of California, San Francisco; Jean C. Lee, Harvard Medical School; Jay A. Levy, University of California, San Francisco; Stuart B. Levy, Tufts University, New England Medical Center Hospitals; Lloyd Mayer, Mount Sinai School of Medicine; Samuel I. Miller, University of Washington; Robert L. Modlin, University of California, Los Angeles; Edward Penhoet, University of California, Berkeley; Daniel A. Portnoy, University of California, Berkeley; Lalita Ramakrishnan, Stanford University School of Medicine; Rino Rappuoli, Research Institute of Chiron SpA, Siena; Arthur Reingold, University of California, Berkeley; Lee W. Riley, University of California, Berkeley; Philip J. Rosenthal, University of California, San Francisco; Molly B. Schmid, Microcide Pharmaceuticals; Paul M. Sullam, University of California, San Francisco; Lee Wetzler, Boston University School of Medicine. The organizing committee comprised Drs. Brooks, Chambers, Engel, Ernst, Gerberding, Griffiss, Koehler, J. A. Levy (Chair), Reingold, Riley, Rosenthal, and Sullam.

Journal Article.  0 words. 

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.